• Diagnose cancer cachexia in pancreatic cancer and identify exocrine pancreatic insufficiency as a coexisting, treatable driver of weight loss.
• Manage cachexia complicated by chemotherapy-induced nausea and early satiety, using enzyme replacement, olanzapine, and modification of an existing exercise regimen.

This activity is supported by an educational grant from Pfizer.